Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OptimizeRx (OPRX) Interest Expenses (2016 - 2025)

Historic Interest Expenses for OptimizeRx (OPRX) over the last 7 years, with Q3 2025 value amounting to $1.2 million.

  • OptimizeRx's Interest Expenses fell 2427.82% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year increase of 2216.18%. This contributed to the annual value of $6.2 million for FY2024, which is 32365.89% up from last year.
  • Latest data reveals that OptimizeRx reported Interest Expenses of $1.2 million as of Q3 2025, which was down 2427.82% from $1.6 million recorded in Q2 2025.
  • In the past 5 years, OptimizeRx's Interest Expenses registered a high of $1.6 million during Q2 2025, and its lowest value of $1.2 million during Q3 2025.